Since June, Michel has served as interim dean and was previously chair of the Department of Pharmaceutical Sciences and associate dean for graduate programs.

Shapiro and UMSOM’s Jeffrey Hasday, MD, honored for discovery of a novel class of drugs that selectively inhibits an enzyme’s role in promoting disease-causing inflammation and has been licensed to GEn1E Lifesciences.

Former dean receives the Hartmut Derendorf Mentorship in Clinical Pharmacology Award.

When Natalie D. Eddington stepped down as dean this spring, it marked the end of a more than 15-year tenure spent in service to academic pharmacy filled with laudable accomplishments.

Six major drug agencies participated in workshop.

Nearly 1,000 students are enrolled in the School’s 10 programs.

Regulatory science center will receive up to $50 million over five years.

Aziza Frank is a PhD candidate in the Department of Pharmaceutical Sciences.

$500,000 gift will support five initiatives at the School and university.

School received more than $25 million for research in the fiscal year 2022.

More than 200 attendees joined in person or virtually for biannual event.

Event featured oral and poster sessions, plus a career panel.